IER5L and neoplasm: Mechanistically, our results indicate that the tumor suppressive phenotype elicited upon IER5L targeting is associated to changes in the transcriptional program of proliferation and monomeric G protein regulators such as RCC2 and ARHGEF1 [19–21].